The authorization of the Pfizer vaccine for children under five years of age is postponed; Study Finds Even Mild Cases of COVID-19 Increase Heart Disease Risk

The United States Food and Drug Administration has postponed the emergency use authorization requested by the company Pfizer for its vaccine against COVID-19 intended for children between six months and four years of age. Pfizer maintains that a clinical trial concluded that two low doses of its vaccine had limited efficacy in preventing severe cases of the disease in children between the ages of two and four. The pharmaceutical company is now evaluating whether a third dose generates a stronger immune response in children.

In other medical news, a new study reveals that COVID-19 can significantly increase the risk of cardiovascular disease, even in patients who have fully recovered from mild cases of coronavirus. The research, published in the journal Nature Medicine, found that in people who had had coronavirus and were not vaccinated, the risk of stroke increased by more than 50% and the risk of heart failure increased by more than 70%. % within the first year after infection.

The director-general of the World Health Organization called for an exemption from intellectual property protections for coronavirus vaccines during a visit to a vaccine-producing company in South Africa. Tedros Adhanom Ghebreyesus said ending the “acute phase” of the pandemic is within our reach if 70% of the world’s population is vaccinated by the middle of this year.

Tedros Adhanom Ghebreyesus: “It is not a matter of chance, it is a matter of choice. If the world wants to end the pandemic, it has the means to do so. If you want to stay greedy instead of getting out of the pandemic, then the pandemic will not end.”

—